ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.

There is strong epidemiologic evidence indicating that common genetic variability could be implicated in pancreatic cancer risk and, to date, various loci have been proposed. In particular, there is increasing evidence of the involvement of ABO gene variability an...

Bibliografski detalji
Glavni autori:	Rizzato, C, Campa, D, Pezzilli, R, Soucek, P, Greenhalf, W, Capurso, G, Talar-Wojnarowska, R, Heller, A, Jamroziak, K, Khaw, K, Key, T, Bambi, F, Landi, S, Mohelnikova-Duchonova, B, Vodickova, L, Büchler, M, Bugert, P, Vodicka, P, Neoptolemos, J, Werner, J, Hoheisel, J, Bauer, A, Giese, N, Canzian, F
Format:	Journal article
Jezik:	English
Izdano:	2013

Slični predmeti

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.
od: Campa, D, i dr.
Izdano: (2013)

Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
od: Campa, D, i dr.
Izdano: (2017)

Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study
od: Campa, D, i dr.
Izdano: (2018)

Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
od: Campa, D, i dr.
Izdano: (2013)

Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study
od: Campa, D, i dr.
Izdano: (2017)

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.
od: Campa, D, i dr.
Izdano: (2017)

Pancreatic cancer susceptibility loci and their role in survival
od: Rizzato, C, i dr.
Izdano: (2011)

Pancreatic cancer susceptibility loci and their role in survival
od: Rizzato, C, i dr.
Izdano: (2011)

Somatic mutations in exocrine pancreatic tumors: association with patient survival.
od: P Sivaramakrishna Rachakonda, i dr.
Izdano: (2013-01-01)

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue.
od: Andrea S Bauer, i dr.
Izdano: (2012-01-01)

Pancreatic cancer susceptibility loci and their role in survival.
od: Cosmeri Rizzato, i dr.
Izdano: (2011-01-01)

Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms
od: Obazee, O, i dr.
Izdano: (2017)

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.
od: Campa, D, i dr.
Izdano: (2016)

Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival
od: Manuel Gentiluomo, i dr.
Izdano: (2021-04-01)

Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma
od: Lenka Cervenkova, i dr.
Izdano: (2019-12-01)

Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women
od: Giulia Peduzzi, i dr.
Izdano: (2022-10-01)

Palladin mutation causes familial pancreatic cancer: absence in European families.
od: Emily Slater, i dr.
Izdano: (2007-04-01)

Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk
od: Ye Lu, i dr.
Izdano: (2021-12-01)

Acute pancreatitis associated with massive paraesophageal hernia involving the presence of the pancreatic body and tail
od: Bahjat Barakat, i dr.
Izdano: (2018-12-01)

Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
od: Ye Lu, i dr.
Izdano: (2021-08-01)

The status and prospects of stroke rehabilitation rese
od: Yi WU, i dr.
Izdano: (2011-04-01)

Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression
od: Manuel Gentiluomo, i dr.
Izdano: (2023-06-01)

Current Rectification in a Structure: ReSe2/Au Contacts on Both Sides of ReSe2
od: Tingting Miao, i dr.
Izdano: (2019-01-01)

Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk
od: Pelin Ünal, i dr.
Izdano: (2024-02-01)

Neuropathic Pain in Pancreatic Cancer: An Update of the Last Five Years
od: Raffaele Pezzilli
Izdano: (2021-06-01)

Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians
od: Margherita Piccardi, i dr.
Izdano: (2023-08-01)

Heart in acute pancreatitis: facts and fictions
od: Raffaele Pezzilli, i dr.
Izdano: (2015-10-01)

Rese a: Libro Colombia elecciones 2000
od: Fernando Giraldo García, i dr.
Izdano: (2001-01-01)

Clinical Impact of Molecular Subtyping of Pancreatic Cancer
od: Xu Zhou, i dr.
Izdano: (2021-11-01)

Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
od: Carl S. Leonhardt, MD, i dr.
Izdano: (2020-03-01)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
od: Raffaele Pezzilli, i dr.
Izdano: (2011-07-01)

Invasion and metastasis in pancreatic cancer
od: Büchler Markus W, i dr.
Izdano: (2003-01-01)

Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
od: Xu Zhou, i dr.
Izdano: (2023-03-01)

Natural history of SPINK1 germline mutation related-pancreatitis
od: Nelly Muller, i dr.
Izdano: (2019-10-01)

Management of acute pancreatitis: current knowledge and future perspectives
od: Tomassetti Paola, i dr.
Izdano: (2006-05-01)

New acquisitions in treating infection due to necrotic pancreatitis: prevention or cure?
od: Raffaele Pezzilli, i dr.
Izdano: (2008-06-01)

NSAIDs and Acute Pancreatitis: A Systematic Review
od: Roberto Corinaldesi, i dr.
Izdano: (2010-03-01)

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
od: Mariia Kiriukova, i dr.
Izdano: (2020-09-01)

New molecular aspects in pathogenesis and progression of pancreatic cancer
od: Büchler Markus W, i dr.
Izdano: (2003-01-01)

GATA6 immunohistochemistry and prognosis after surgical resection of pancreatic adenocarcinoma: results from the ESPAC-4 trial
od: R.C. Grant, i dr.
Izdano: (2025-06-01)